Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

5
The $250 Biohack That’s Revolutionizing Life With Diabetes - Bloomberg

2018-08-08 bloomberg - 1
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RHHVF AAPL RHHBY DXCM RHHBF MDT

0
Roche: How It Can Rise Despite The Patent Cliff (Part 1 Of 2)

2018-08-08 seekingalpha
The long-feared patent cliff/slope for Roche's Big 3 drugs has begun to hit Rituxan/MabThera in the EU.
RHHVF RHHBY RHHBF

6
Zero-Sales Biotechs May Damage Your Financial Health - Bloomberg

2018-08-08 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
JBK PFZ GSC TFG PFIZER GSJ RHHBF GS GLSSP RHHVF RHHBY BGNE GJS 500680 PFE

51
Tracking Tweedy Browne Portfolio - Q2 2018 Update

2018-08-06 seekingalpha
The largest five individual stock positions are Cisco Systems, Baidu Inc., Berkshire Hathaway, Alphabet, and Johnson & Johnson and they account for ~49% of the portfolio.
PSX AZO RDSB RDSA MRC RHHBF HSB RHHVF CSCO GSK CMCSK CTWS TMK HCS AVT BRK.A HEIO GOOGL JNJ BK RYDBF NVS VZ WFCNP TMK MTSI CCV DVN CCZ BAX GOOG VZA SAFRF COP CKX ANAT RYDAF BIDU HSBC DEO AGCO HBCYF WFC CTWSP FP CTWSO SAFRY RDS.B RDS.A UNP CMCSA MA GSK 0005 SAF CCV.CL KHC HSEA RHHBY HSEB UNF

0
Roche Holding (RHHBY) American Society Of Retina Specialists 36th Annual Meeting - Slideshow

2018-08-03 seekingalpha
The following slide deck was published by Roche Holding Ltd ADR in conjunction with this event.
RHHVF RHHBY RHHBF

8
To Get the Latest Drugs, Head to China

2018-08-03 theedgemarkets - 1
(Aug 3): It’s been less than a year since Beijing cut back red tape on drug approvals and already Chinese patients can expect to get some breakthrough medicines before Americans.
HNCMF RHHVF AZN RHHBY GSK HCM HCM GSK IQV RHHBF

8
To Get the Latest Drugs, Head to China - Bloomberg

2018-08-03 bloomberg - 1
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
HNCMF RHHVF AZN RHHBY GSK HCM HCM GSK IQV RHHBF

0
Roche's Bet On Allakos Is Too Expensive

2018-08-01 seekingalpha
Allakos is expected to have $195 million in cash after the IPO. It means that the shares are trading at 8.3x its cash, which is not common in pharmaceutical IPOs.
BPMC RHHVF RHHBY ALLK RHHBF

5
What's in Store for Immune Design (IMDZ) in Q2 Earnings?

2018-07-30 zacks
Immune Design Corp. (IMDZ - Free Report) is scheduled to report second-quarter 2018 results after the market closes on Aug 1.
RHHVF IMDZ PCRX RHHBY ENL ENDP RHHBF

13
Roche (RHHBY) 1H18 Revenues Up Y/Y on Solid New Drug Sales

2018-07-27 zacks
Swiss pharma giant Roche Holding AG (RHHBY - Free Report) reported solid sales growth in the first half of 2018 as well as in the second quarter, propelled by growth in sales of new drugs. The company also upped its annual guidance for the second time in 2018.
EA AMGN RHHVF RHHBY NVS ABBV NVR FMI TRN ABBV RHHBF

0
Trump Opens a Dangerous New Trade-War Front - Bloomberg

2018-07-20 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
RHHVF RHHBY DTK RHHBF

0
Allergan, Molecular Partners eye drug meets main goal in two studies

2018-07-19 reuters
(Reuters) - Allergan Plc and Molecular Partners AG said on Thursday their treatment for age-related macular degeneration met the main goal in two late-stage studies.
RHHVF AGN RHHBY ACT RHHBF

0
Allergan, Molecular Partners eye drug meets main goal in two studies - Channel NewsAsia

2018-07-19 channelnewsasia
Allergan Plc and Molecular Partners AG said on Thursday their treatment for age-related macular degeneration met the main goal in two late-stage studies.
RHHVF AGN RHHBY ACT RHHBF

1
Roche's Tecentriq Gets Breakthrough Therapy Status for HCC

2018-07-18 zacks - 1
Roche Holding AG (RHHBY - Free Report) announced that the FDA has granted breakthrough therapy designation to its immuno-oncology drug, Tecentriq, in combination with Avastin for the first-line treatment of advanced hepatocellular carcinoma (HCC).
RHHVF EXEL VNDA RHHBY ILMN RHHBF

30
Superbugs Win Another Round as Big Pharma Leaves Antibiotics - Bloomberg

2018-07-13 bloomberg - 2
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
AZN PRTK MDCO MTFB MLNT ACT GSK RHHBF MTFBF RHHVF AGN RHHBY NVS GSK AKAO

Related Articles

RNVA: Rennova Health Analysis and Research Report

2018-08-18 - Asif

Business overview Rennova Health, Inc. (together with its subsidiaries, “Rennova”, “we” or the “Company”) is a provider of an expanding group of health care services for healthcare providers, patients and individuals. Beginning in 2018, the Company intends to focus on and operate two synergistic divisions: 1) Clinical diagnostics through its clinical laboratories; and 2) Hospital operations through its Big South Fork Medical Center, which opened on August 8, 2017, and a hospital in Jamestown Tennessee, including a doctor’s practice, the assets of which the company expect to acquire in the second quarter of 2018, pursuant to the terms of a definitive asset purchase agreement that the company entered into on January 31, 2018, as more fully discussed below. The company believe that its approach will produce a more sustainable business model and the capture of multiple revenue streams from medical providers, patients and hospital services. Management determined that because Big So...

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

CUSIP: 0000ROCHE